Glutoxim solution for injections 3% 1ml. ampoules №5

Description

Glutoxim 3% Composition

active substance:
Excipients:

Glutoxim 3% Dosage form

Injection.

Glutoxim 3% Pharmacological group

ATC code L0ZAX.

Indications

As a means of prevention and treatment in adults of secondary immunodeficiency conditions associated with radiation, chemical and infectious factors
to restore suppressed immune reactions and a depressed state of bone marrow hematopoiesis
to increase the body’s resistance to various pathological influences – infectious agents, chemical and / or physical factors (intoxication, radiation, etc.)
as a hepatoprotective agent for chronic viral hepatitis B and C
for potentiating the therapeutic effects of antibacterial therapy of chronic obstructive pulmonary diseases
for the prevention of postoperative purulent complications
as part of complex anti-tuberculosis therapy of severe common forms of tuberculosis of all localizations
in the presence of drug resistance of mycobacterium tuberculosis to drugs
for the prevention of exacerbations of chronic hepatitis in patients with tuberculosis against the background of anti-tuberculosis therapy
for the treatment of toxic complications of anti-tuberculosis therapy
as part of the complex therapy of psoriasis, including moderate and severe forms with the presence of erythroderma, arthropathy
as part of the complex therapy of malignant neoplasms in oncology for the prevention and treatment of toxic manifestations of chemotherapy and radiation therapy, namely: it helps to reduce hematotoxic and hepatotoxic effects, contributes to the effective restoration of the functions of bone marrow hematopoiesis during antitumor therapy. To eliminate the manifestations of a nonspecific disease syndrome (anemia, fatigue, loss of appetite, increased pain sensitivity).

Contraindications

The use of the drug is contraindicated in cases of individual hypersensitivity to the components of the drug.

Method of administration and dosage

The drug Glutoxim is administered intravenously, intramuscularly, subcutaneously. Assign 5-40 mg daily (for 1 course – 50-300 mg), depending on the nature of the disease.

For prophylactic purposes, the drug is used intramuscularly daily at 5-10 mg for 2 weeks.

As part of the complex therapy of tuberculosis, Glutoxim 60 mg is administered 1 time per day for the first 10 days daily intramuscularly, for the next 20 days Glutoxim 60 mg is administered intramuscularly every other day, one injection per day.

If necessary, a second course of treatment is carried out in 1-6 months.

As part of the complex therapy of psoriasis, Glutoxim is used intramuscularly daily at a daily dose of 10 mg for 15 days, then for another 5 weeks 2 times a week at a daily dose of 10 mg. Only 25 injections per treatment course.